Citadel Advisors »

Newamsterdam Pharma Co Nv shares owned by Citadel Advisors

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $235k 21k 11.17
2023-09-30 $290k 31k 9.25

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Viking Global Investors
RA Capital Management
Medicxi Ventures Management
BVF
Goldman Sachs Group
GMT Capital Corp
Millennium Management
Alyeska Investment Group
Opaleye Management
Schonfeld Strategic Advisors
Marshall Wace
Yarbrough Capital
HealthInvest Partners AB

View all funds holding Newamsterdam Pharma Co Nv